Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 612
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT00291148 Neuropathic Pain Assessment Comparing Pregabalin and Paroxetine in Mana… |
paroxetine | SEP | Phase 3 | COMPLETED | En attente / non publié | University of California, Irvine | Canada · Multiple Sclerosis Clinic, Health Sciences C… | 2006-03 → 2012-07 | Ouvrir |
| NCT02905227 A Study of the Pulmonary Safety and Pharmacokinetics of Zolmitriptan In… |
CVT-427 (zolmitriptan inhalation … | Migraine | Phase 1 | COMPLETED | En attente / non publié | Acorda Therapeutics | United States · Site #101, Dallas, United States | Si… | 2016-09 → 2016-12 | Ouvrir |
| NCT03898180 Study of First-line Pembrolizumab (MK-3475) With Lenvatinib (MK-7902/E7… |
Pembrolizumab | Parkinson | Phase 3 | COMPLETED | En attente / non publié | Merck Sharp & Dohme LLC | United States, Argentina, Australia, Canada, China, D… | 2019-05-06 → 2024-05-20 | Ouvrir |
| NCT07164924 FERTIMUS — Evaluation of the Impact of Multiple Sclerosis and Its Treat… |
blood sample to analyse AMH level… | SEP | À vérifier | COMPLETED | En attente / non publié | University Hospital, Clermont-Fer… | France, Martinique · AP-HM, Marseille, France | AP-HP… | 2018-01-01 → 2024-12-08 | Ouvrir |
| NCT05090033 EAFToS — Characterizing the Use of Ofatumumab in a Real World Setting |
EAFToS — Characterizing the Use o… | SEP | À vérifier | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | Australia · Novartis Investigative Site, Clayton, Aus… | 2022-12-08 → 2026-02-06 | Ouvrir |
| NCT03589105 PRO-MSACTIVE — A Study to Provide Complementary Efficacy, Safety and Pa… |
Ocrelizumab 300 mg | SEP | Phase 4 | COMPLETED | En attente / non publié | Hoffmann-La Roche | France · Centre hospitalier Andre Mignot; Neurologie,… | 2018-08-06 → 2021-02-15 | Ouvrir |
| NCT02485223 STAR-MS — Single Test to ARrive at MS Diagnosis. Using a Single MRI Bra… |
STAR-MS — Single Test to ARrive a… | SEP | À vérifier | UNKNOWN | En attente / non publié | University of Nottingham | United Kingdom · Clinical Neurology, Division of Clin… | 2015-05 → 2017-05 | Ouvrir |
| NCT06920524 Interest of a Musical Intervention on Stress Induced During Botulinum T… |
Intervention group IM-IM | SEP | NA | RECRUITING | En attente / non publié | University Hospital, Clermont-Fer… | France · CHU de Clermont-Ferrand, Clermont-Ferrand, F… | 2025-04-25 → 2027-10-30 | Ouvrir |
| NCT03436927 Comparison of Two Different Virtual Reality Methods in Patients With Mu… |
Comparison of Two Different Virtu… | SEP | NA | COMPLETED | En attente / non publié | Biruni University | Non communiqué | 2016-07-15 → 2017-07-15 | Ouvrir |
| NCT05605782 ORION — A Post-Authorization, Long-term Study of Ozanimod Real-world Sa… |
ORION — A Post-Authorization, Lon… | SEP | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | Bristol-Myers Squibb | United States · Evidera, Bethesda, United States | 2021-09-02 → 2033-07-26 | Ouvrir |
| NCT01371760 BRAVE-DREAMS (BRAin VEnous DRainage Exploited Against Multiple Sclerosi… |
Venous PTA | SEP | NA | COMPLETED | En attente / non publié | S. Anna Hospital | Italy · S. Anna Hospital, Ferrara, Italy | S. Anna Ho… | 2012-08 → 2015-12 | Ouvrir |
| NCT00283738 MIST II PFO-Migraine Trial With BioSTAR® Bioabsorbable Septal Repair Im… |
BioSTAR Septal Repair Implant Sys… | Migraine | Phase 2 | UNKNOWN | En attente / non publié | NMT Medical | United States · New England Center for Headache, Stam… | 2006-02 → 2008-03 | Ouvrir |
| NCT01773252 PFO Detection — Right to Left Cardiac Shunt Detection |
Flow Detection System | Migraine | Phase 3 | TERMINATED | En attente / non publié | Cardiox Corporation | United States · Columbia University Medical Center, N… | 2012-11 → 2015-11 | Ouvrir |
| NCT05762003 CPE — Czech Pharmaco-epidemiological Study on Disease Modifying Drugs |
interferons, glatiramer acetate, … | SEP | À vérifier | COMPLETED | En attente / non publié | IMPULS Endowment Fund | Czechia · IMPULS Endowment Fund, Prague, Czechia | 2019-01-01 → 2021-12-31 | Ouvrir |
| NCT03853746 Short-term B-cell Depletion in Relapsing Multiple Sclerosis |
Ocrelizumab | SEP | Phase 4 | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States · Johns Hopkins University, Baltimore, … | 2019-04-01 → 2024-07-01 | Ouvrir |
| NCT03535298 DELIVER-MS — Determining the Effectiveness of earLy Intensive Versus Es… |
Early Highly Effective Therapies … | SEP | Phase 4 | ACTIVE_NOT_RECRUITING | En attente / non publié | The Cleveland Clinic | United States, United Kingdom · Aneurin Bevan Local H… | 2019-01-03 → 2027-07-30 | Ouvrir |
| NCT03157830 OCTAVE — Evaluating the Efficacy and Safety of Transitioning Patients F… |
OCTAVE — Evaluating the Efficacy … | SEP | À vérifier | COMPLETED | En attente / non publié | Providence Health & Services | United States · Kadlec Neuroscience Center, Richland,… | 2017-06-01 → 2022-06-06 | Ouvrir |
| NCT05334472 A Survey to Evaluate Early Experience From Patient and Care Partner on … |
A Survey to Evaluate Early Experi… | SEP | À vérifier | COMPLETED | En attente / non publié | Novartis Pharmaceuticals | United States · Novartis Investigative Site, East Han… | 2021-11-24 → 2023-02-15 | Ouvrir |
| NCT01723631 TRAP-Myéline — Analyze the Myelin-TRAP as Diagnostic Tool in Multiple S… |
Trap Myelin Test | SEP | NA | TERMINATED | En attente / non publié | Nantes University Hospital | France · Hopital neurologigue Pierre Wertheimer, Bron… | 2012-04 → 2015-10 | Ouvrir |
| NCT04379193 Physical Therapy and Neuroactive Steroids Therapy Does Not Modulate Ser… |
Physical Therapy and Neuroactive … | SEP | NA | COMPLETED | En attente / non publié | Charles University, Czech Republic | Non communiqué | 2015-05-20 → 2019-09-01 | Ouvrir |
| NCT01804660 CONTROL — Longitudinal Therapeutically Non-interventional Study of MSRV… |
CONTROL — Longitudinal Therapeuti… | SEP | À vérifier | COMPLETED | En attente / non publié | GeNeuro Innovation SAS | France · Etablissement Français du Sang Rhône Alpes -… | 2012-10 → 2013-12 | Ouvrir |
| NCT02782858 CHANGE-MS — Clinical Trial Assessing the HERV-W Env Antagonist GNbAC1 f… |
GNbAC1 | SEP | Phase 2 | COMPLETED | En attente / non publié | GeNeuro Australia PTY Ltd | Bulgaria, Croatia, Czechia, Estonia, Germany, Hungary… | 2016-04 → 2017-12 | Ouvrir |
| NCT04838015 SEP-RR — Retrospective Study on Registry Data to Evaluate the Impact of… |
SEP-RR — Retrospective Study on R… | SEP | À vérifier | UNKNOWN | En attente / non publié | University Hospital, Strasbourg, … | France · Hautepierre Clinical Investigation Center - … | 2020-11-13 → 2021-11-13 | Ouvrir |
| NCT03873389 Ocrelizumab Effects on the Metabolome in MS |
Ocrelizumab | SEP | À vérifier | COMPLETED | En attente / non publié | Hoffmann-La Roche | United States · Johns Hopkins University, Baltimore, … | 2019-06-12 → 2023-12-05 | Ouvrir |
| NCT05269888 CoVaR-MS — Covid-19 Vaccine Immune Response in Multiple Sclerosis |
CoVaR-MS — Covid-19 Vaccine Immun… | SEP | À vérifier | ACTIVE_NOT_RECRUITING | En attente / non publié | University Hospitals of North Mid… | United Kingdom · University Hospitals of North Midlan… | 2022-02-16 → 2025-12-30 | Ouvrir |